Yhdysvallat - englanti - NLM (National Library of Medicine)

dominion veterinary laboratories ltd. - ammonium carbonate (unii: nj5vt0fklj) (ammonium cation - unii:54s68520i4), camphor oil (unii: 75izz8y727) (camphor oil - unii:75izz8y727), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), potassium bicarbonate (unii: hm5z15lebn) (potassium cation - unii:295o53k152) - to help provide temporary relief and aid in the treatment of coughs of colds, bronchial irritations and stable cough.

Yhdysvallat - englanti - NLM (National Library of Medicine)

rubimed ag - ammonium carbonate (unii: nj5vt0fklj) (ammonium cation - unii:54s68520i4, carbonate ion - unii:7ujq5ope7d), graphite (unii: 4qqn74lh4o) (graphite - unii:4qqn74lh4o), quinine arsenite (unii: 42qo5p0nlm) (quinine - unii:a7v27phc7a, arsenite ion - unii:n5509x556j), opium (unii: 37m3mz001l) (opium - unii:37m3mz001l), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i) - ammonium carbonate 800 [hp_c] in 1 ml - homeopathic preparation for general well-being: feeling isolated

Yhdysvallat - englanti - NLM (National Library of Medicine)

king bio inc - ammonium carbonate (unii: nj5vt0fklj) (ammonium cation - unii:54s68520i4), antimony arsenate (unii: we3458xnft) (antimony arsenate - unii:we3458xnft), antimony potassium tartrate (unii: dl6oz476v3) (antimony - unii:9it35j3uv3), arsenic trioxide (unii: s7v92p67ho) (arsenic trioxide - unii:s7v92p67ho), bromine (unii: sbv4xy874g) (bromine - unii:sbv4xy874g), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), chlorine (unii: 4r7x1o2820) (chlorine - unii:4r7x1o2820), potassium c - ammonium carbonate 10 [hp_x] in 59 ml - hpus active ingredients                   purpose ammonium carbonicum........slow, labored breathing, hoarseness antimonium arsenicicum.......cough and much mucus antimonium tartaricum...........rapid, difficult breathing, bronchial mucus arsenicum album.................wheezing respiration, burning in chest bromium.............................spasmodic coughing carbo vegetabilis.................coughing attacks, expelling mucus chlorinum............................increased mucus, hoarseness kali carbonicum..................wheezing, dry cough, cutting pain in chest lobelia inflata......................oppression of chest, ringing cough, short breaths stannum metallicum............cough at night, hoarseness, fever sulphuricum acidum............rapid respiration, bronchial inflammation

Yhdysvallat - englanti - NLM (National Library of Medicine)

b. braun medical inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride 14.9 g in 100 ml - potassium chloride for injection concentrate usp is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. this is a concentrated solution which is intended for use in a pharmacy admixture service and is restricted to the preparation of admixtures for intravenous infusion. potassium chloride for injection concentrate usp is contraindicated in diseases where high potassium levels may be encountered, in patients with hyperkalemia, renal failure and in conditions in which potassium retention is present, or where additives of potassium and chloride could be clinically detrimental.

Yhdysvallat - englanti - NLM (National Library of Medicine)

hospira, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride 10 meq in 100 ml - potassium chloride injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. this highly concentrated, ready-to-use potassium chloride injection is intended for the maintenance of serum k + levels and for potassium supplementation in fluid restricted patients who cannot accommodate additional volumes of fluid associated with potassium solutions of lower concentration. when using these products, these patients should be on continuous cardiac monitoring and frequent testing for serum potassium concentration and acid-base balance. potassium chloride injection is contraindicated in diseases where high potassium levels may be encountered, and in patients with hyperkalemia, renal failure and in conditions in which potassium retention is present.

Yhdysvallat - englanti - NLM (National Library of Medicine)

wockhardt limited - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 100 mg - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of depressed inpatients and in one 6-week controlled trial of depressed outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical pharmacology). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a

Yhdysvallat - englanti - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of depressed inpatients and in one 6-week controlled trial of depressed outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical pharmacology). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a

Yhdysvallat - englanti - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - ammonium lactate (unii: 67m901l9nq) (lactic acid, unspecified form - unii:33x04xa5at) - ammonium lactate cream, 12% is indicated for the treatment of ichthyosis vulgaris and xerosis. ammonium lactate cream, 12% is contraindicated in those patients with a history of hypersensitivity to any of the label ingredients.

Yhdysvallat - englanti - NLM (National Library of Medicine)

remedyrepack inc. - ammonium lactate (unii: 67m901l9nq) (lactic acid - unii:33x04xa5at) - ammonium lactate cream, 12% is indicated for the treatment of ichthyosis vulgaris and xerosis. ammonium lactate cream, 12% is contraindicated in those patients with a history of hypersensitivity to any of the label ingredients.

Yhdysvallat - englanti - NLM (National Library of Medicine)

bryant ranch prepack - ammonium lactate (unii: 67m901l9nq) (lactic acid - unii:33x04xa5at) - ammonium lactate cream, 12% is indicated for the treatment of ichthyosis vulgaris and xerosis. ammonium lactate cream, 12% is contraindicated in those patients with a history of hypersensitivity to any of the label ingredients.